Showing 1 - 10 of 13
A famous idea to maintain affordable health expenditures is to cut back statutory health insurance (SHI) to a basic insurance and to introduce supplementary private health insurance (PHI), permitted to cover the remaining benefits and to apply managed care mechanisms. The measure is supposed to...
Persistent link: https://www.econbiz.de/10010266017
This paper analyses the relationship between locus of control (LOC) and the demand for supplementary health insurance. Drawing on longitudinal data from Germany, we find robust evidence that individuals having an internal LOC are more likely to take up supplementary private health insurance...
Persistent link: https://www.econbiz.de/10012657963
We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. First, we construct a vertical...
Persistent link: https://www.econbiz.de/10010274913
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies' substitution...
Persistent link: https://www.econbiz.de/10010291561
This paper studies a market for a medical product in which there is perfect competition among health insurers, while the good is sold by a monopolist. Individuals differ in their severity of illness and there is ex post moral hazard. We consider two regimes: one in which insurers use coinsurance...
Persistent link: https://www.econbiz.de/10013221173
We study the impact of short-term exposure to ambient air pollution on the spread and severity of Covid-19 in Germany. We combine data on county-by-day level on confirmed cases and deaths with information on local air quality and weather conditions and exploit short-term variation in the...
Persistent link: https://www.econbiz.de/10012269565
We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is estimated to have increased mean age at death by...
Persistent link: https://www.econbiz.de/10010283600
In order to get the COVID-19 pandemic under control, most governments around the globe have adopted some sort of containment policies. In the light of the enormous costs of these policies, in many countries highly controversial discussions on the adequacy of the chosen policies evolved. We...
Persistent link: https://www.econbiz.de/10012827114
To fight the spread of COVID-19, many countries implemented unprecedented social distancing policies. This is the first paper that uses an event-study approach to examine the effects of the German social distancing policies on (a) individual behavior and (b) the spread of the epidemic. Combining...
Persistent link: https://www.econbiz.de/10012830991
The average height of children is an indicator for the quality of nutrition and health care. Heights have never declined over longer time spans in Eastern Germany since 1880 - except for the most recent period 1997-2006. In the Eastern German Land of Brandenburg, a data set of 253,050 pre-school...
Persistent link: https://www.econbiz.de/10013316616